Medical News

RSS

Opexa Therapeutics to present data from Phase 2b TERMS clinical trial for Tovaxin at 62nd AAN meeting

Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.

7 Apr 2010

Eating protein-rich eggs for breakfast reduces hunger, decreases calorie consumption throughout the day

A new study demonstrates that eating protein-rich eggs for breakfast reduces hunger and decreases calorie consumption at lunch and throughout the day. The study, published in the February issue of Nutrition Research, found that men who consumed an egg-based breakfast ate significantly fewer calories when offered an unlimited lunch buffet compared to when they ate a carbohydrate-rich bagel breakfast of equal calories.

7 Apr 2010

Guidant imposed criminal penalty over $296M for withholding cardioverter defibrillator failure information

Guidant LLC pleaded guilty today in St. Paul, Minn., before U.S. District Court Judge Donovan W. Frank to criminal violations of the Federal Food, Drug and Cosmetic Act, the Justice Department announced. The medical device manufacturer's admission of criminal wrongdoing is the result of a four-year investigation into Guidant's handling of short-circuiting failures of three models of its implantable cardioverter defibrillators: the Ventak Prizm 2 DR (Model 1861) and the Contak Renewal (Models H135 and H155).

7 Apr 2010

African-American women with advanced breast cancer have poorer survival rates

African-American women have poorer survival rates than their white and Hispanic counterparts regardless of whether they receive radiation therapy following lumpectomy or mastectomy, UC Davis researchers have found.

7 Apr 2010

Nationwide Phase III clinical trial of OncoVEX for advanced melanoma

Rush University Medical Center is leading a nationwide Phase III clinical trial to determine whether a promising vaccine for advanced melanoma can effectively treat the deadly skin cancer.

7 Apr 2010

Toronto Star examines cost of fighting maternal mortality, Canada's G8 initiative

Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.

7 Apr 2010

AbleNet adds Madentec's entire line of assistive technology solutions to product portfolio

AbleNet, Inc. announces the agreement with Madentec Limited of Edmonton, Alberta, Canada for the exclusive global rights to manufacture and sell their entire line of assistive technology solutions. This adds a broad portfolio of proven devices to the AbleNet computer access products. Madentec will continue to own the products and provide engineering development support, which has been their core strength.

7 Apr 2010

Brumby endorses Nixon and her appointment

In a public statement Mr Brumby released he endorsed Nixon and her appointment. Mr Brumby stated, “Christine has said that she should have done things differently on Black Saturday. It is important that we wait for the recommendations of the Royal Commission before passing judgment. Christine and the Victorian Bushfire Reconstruction and Recovery Authority have been crucial to helping fire-affected communities rebuild. The Government supports Christine continuing in her role at VBRRA.’’

7 Apr 2010

Traffic-related pollution near schools contributes to pediatric asthma

Living near major highways has been linked to childhood asthma, but a new study led by researchers at the Keck School of Medicine of the University of Southern California suggests that traffic-related pollution near schools is also contributing to the development of asthma in kids.

7 Apr 2010

Update on Aerocrine AB's patent infringement cases against Apieron

Aerocrine AB today announced that its patent infringement cases in the U.S. and Europe against Apieron Inc., Menlo Park, USA will be stayed as a result of Apieron filing for Chapter 7 bankruptcy.

7 Apr 2010

OXiGENE regains compliance for continued listing on NASDAQ Global Market

OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has received a letter from NASDAQ Global Market exchange confirming that, with the appointment of Tamar Howson to the Company's audit committee, as detailed in the Company's Form 8-K filed on April 5, 2010, NASDAQ staff has determined that the Company complies with Listing Rule 5605(c)(2)

7 Apr 2010

Media outlets examine urbanization, health ahead of World Health Day

Several media outlets examine the health risks associated with rapid urbanization around the world - the theme of this year's World Health Day, to be marked on Wednesday.

7 Apr 2010

Optimer Pharmaceuticals to present data from fidaxomicin Phase 3 studies at 20th ECCMID

Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.

7 Apr 2010

IAN survey gives grandparents a voice in autism research community

Today, the Interactive Autism Network, www.ianproject.org, the nation's largest online autism research project, announces results of the Grandparents of Children with Autism Spectrum Disorders Survey, finding that nearly one-third of grandparents who participated were the first to raise concerns about their grandchild's development.

7 Apr 2010

BD Diagnostics adds Innova Preanalytical Automated Microbiology Specimen Processor to product portfolio

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today the expansion of its product portfolio with the addition of the BD Innova™ Preanalytical Automated Microbiology Specimen Processor, which is designed to help increase laboratory efficiency and automate the modern microbiology laboratory.

From BD (Becton, Dickinson and Company) 7 Apr 2010

Women with preeclampsia have fewer EPCs: Magee-Womens Research Institute

Compared to women with uncomplicated pregnancies, women with preeclampsia have reduced numbers of special cells that are thought to help grow and maintain blood vessels, according to a study by researchers at the Magee-Womens Research Institute and the University of Pittsburgh School of Medicine.

7 Apr 2010

Obstacles in urban setting limits physical activity and promotes unhealthy food consumption

The conditions of urban environments have been linked to an escalation of noncommunicable diseases such as Type II diabetes, obesity, hypertension, and cardiovascular disease. These diseases are preventable and manageable through exercise, which is why the International Sports Sciences Association (ISSA) is dedicated to stemming the tide of poor health and physical decline by providing distance fitness education to health and fitness professionals, as well as other interested individuals.

7 Apr 2010

Rome Foundation develops Diagnostic Algorithms to diagnose GI symptoms

New clinical algorithms will give physicians a practical, efficient and cost-effective aid to diagnose the frequent gastrointestinal symptoms that patients commonly bring to their primary care doctors and gastroenterologists--symptoms of functional GI disorders that are often difficult to diagnose.

7 Apr 2010

Annual Medicare report delayed to reflect impact of health law, the AP reports

The Associated Press: "The Obama administration is delaying release of the annual report on the financial health of Social Security and Medicare so that the new report can reflect the impact of the recently passed health care overhaul." The AP says that, according to an administration official, the report "will be delayed until June 30, three months later than it usually comes out."

7 Apr 2010

SRU Biosystems extends product line with the introduction of BIND SCANNER

SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.

7 Apr 2010

Medical News

Opexa Therapeutics to present data from Phase 2b TERMS clinical trial for Tovaxin at 62nd AAN meeting

Eating protein-rich eggs for breakfast reduces hunger, decreases calorie consumption throughout the day

Guidant imposed criminal penalty over $296M for withholding cardioverter defibrillator failure information

African-American women with advanced breast cancer have poorer survival rates

Nationwide Phase III clinical trial of OncoVEX for advanced melanoma

Toronto Star examines cost of fighting maternal mortality, Canada's G8 initiative

AbleNet adds Madentec's entire line of assistive technology solutions to product portfolio

Brumby endorses Nixon and her appointment

Traffic-related pollution near schools contributes to pediatric asthma

Update on Aerocrine AB's patent infringement cases against Apieron

OXiGENE regains compliance for continued listing on NASDAQ Global Market

Media outlets examine urbanization, health ahead of World Health Day

Optimer Pharmaceuticals to present data from fidaxomicin Phase 3 studies at 20th ECCMID

IAN survey gives grandparents a voice in autism research community

BD Diagnostics adds Innova Preanalytical Automated Microbiology Specimen Processor to product portfolio

Women with preeclampsia have fewer EPCs: Magee-Womens Research Institute

Obstacles in urban setting limits physical activity and promotes unhealthy food consumption

Rome Foundation develops Diagnostic Algorithms to diagnose GI symptoms

Annual Medicare report delayed to reflect impact of health law, the AP reports

SRU Biosystems extends product line with the introduction of BIND SCANNER

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News